Similar inhibitory effects on proliferation and survival, CCL3/CCL4 secretion, and CXCL12 signaling occur in hairy cell leukemia (HCL) treated with ibrutinib [34]. The gene discussed is CXCL12; the disease is hairy cell leukemia.